Hima Flutura, Gümmer Marjolijn, Prescher Andreas, Altarawneh Bader, Zayat Rachad, Hatam Nima, Ernst Lisa, Kalverkamp Sebastian, Spillner Jan, Arias-Pinilla Jessica
Department of Thoracic and Cardiovascular Surgery, University Hospital RWTH Aachen, Aachen, Germany,
Department of Thoracic and Cardiovascular Surgery, University Hospital RWTH Aachen, Aachen, Germany.
Eur Surg Res. 2019;60(5-6):229-238. doi: 10.1159/000504411. Epub 2019 Nov 19.
Right ventricular failure (RVF) on its own is a life-threatening condition. Often it manifests as a two-organ failure in the final phase of several lung diseases. Mechanical circulatory support is a proven treatment of RVF but remains challenging. Our objective is to develop a novel, simplified, and minimally invasive cannula approach to treat both RVF and respiratory failure.
We conceptualized a dual lumen cannula approach to allow oxygenated right-to-left shunting at an atrial level to decompress right-sided circulation. A minimally invasive approach through percutaneous, transjugular insertion and transseptal placement should enable patients to be non-sedated and even ambulatory. In an iterative design, pre-prototyping, prototyping, and anatomic fitting process, such a cannula was generated and tested in both cadaveric and fluid dynamic studies.
After various modifications and improvements, a 27-Fr 255-mm-long double-lumen cannula with an inner line (oxygenated blood return to patient into the left atrium) of 18 Fr and an inflatable balloon (with a volume of approximately 1 mL) at the outflow tip was produced - one version with a straight head and another one with a curved head. In our anatomic studies, the "Aachen Cannula" allowed an easy transjugular introduction and advancement into the right atrium by Seldinger technique. Transseptal placement was achieved by puncture (Brockenbrough needle) in combination with dilatation and was then secured in place with the stabilizing balloon, even under slight tension. The cannula prototype enabled a flow of up to 3.5 L/min, at which common pressure drops were observed.
In conclusion, we successfully conceptualized, designed, and verified a minimally invasive one-cannula approach for the treatment of either isolated right heart failure and even combined RVF and respiratory failure through our transseptal Aachen Cannula. This concept may also be carried out in ambulatory conditions. Moreover, this approach completely avoids recirculation issues and ensures reliable oxygenated coronary as well as cerebral perfusion.
单纯的右心室衰竭(RVF)是一种危及生命的疾病。它通常在几种肺部疾病的终末期表现为双器官衰竭。机械循环支持是一种已被证实的治疗RVF的方法,但仍然具有挑战性。我们的目标是开发一种新颖、简化且微创的插管方法来治疗RVF和呼吸衰竭。
我们构思了一种双腔插管方法,以允许在心房水平进行氧合的右向左分流,从而减轻右侧循环压力。通过经皮、经颈静脉插入和经房间隔放置的微创方法应使患者无需镇静甚至能够走动。在反复的设计、预原型制作、原型制作和解剖适配过程中,制造了这样一种插管,并在尸体和流体动力学研究中进行了测试。
经过各种修改和改进,制作出了一根27 Fr、255 mm长的双腔插管,其内线(氧合血回流到患者左心房)为18 Fr,流出端有一个可充气气球(体积约为1 mL)——一个版本的头部是直的,另一个版本的头部是弯曲的。在我们的解剖学研究中,“亚琛插管”通过Seldinger技术可以轻松经颈静脉插入并推进到右心房。通过穿刺(Brockenbrough针)结合扩张实现经房间隔放置,然后用稳定气球固定到位,即使在轻微张力下也是如此。插管原型能够实现高达3.5 L/min的流量,此时观察到了常见的压力降。
总之,我们成功地构思、设计并验证了一种微创单插管方法,通过我们的经房间隔亚琛插管来治疗孤立性右心衰竭,甚至是合并的RVF和呼吸衰竭。这个概念也可以在门诊条件下实施。此外,这种方法完全避免了再循环问题,并确保了可靠的氧合冠状动脉以及脑灌注。